AnalystBook Research · Company Intelligence

DELCATH SYSTEMS, INC.

DCTHNasdaq

Built from DELCATH SYSTEMS, INC.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data

Revenue increased 129.1% to $85.2M, while Net income increased 110.2% to $2.7M.

The read at a glance✓ Audited against SEC data
  • Scale — FY2025 revenue $85.2MOK
  • Profitability — Net income $2.7MOK
  • Cash generation — Free cash flow $21.0MOK
  • Accounting — Formula-grey distress score · no manipulation flag · earnings quality safeNote
  • Insiders — 4 buys; 0 sells in 365 daysOK
  • Capital — share repurchases were $6.0MNote

Business

DELCATH SYSTEMS, INC.: This Annual Report on Form 10-K and the information incorporated herein by reference may include trademarks, service marks and trade names owned or licensed by us, including CHEMOFUSE, CHEMOSAT, CHEMOSATURATION, DELCATH, HEPZATO, HEPZATO KIT, PHP and THE DELCATH PHP SYSTEM.

Where the revenue comes from

Fiscal 2025, as DELCATH SYSTEMS, INC. reports it. History and quarterly detail are in the app.

  • HEPZATO KIT$78.8M
  • CHEMOSAT$6.4M

Leadership changes

From DELCATH SYSTEMS, INC.'s own filings, the day they're filed.

  • Martha S. Rook · Chief Operating Officer · appointmenteff. 2024-03-18
  • John Purpura · Chief Operating Officer · appointmenteff. 2024-02-12
  • Roger Stoll · directors · departureeff. 2024-02-09

Latest filings

  • 8-K · Company announcement2026-08-14
  • 8-K · Company announcement2026-08-06
  • 10-Q · Quarterly report2026-08-06
  • 8-K · Company announcement2026-05-14
  • 10-Q · Quarterly report2026-05-07
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about DELCATH SYSTEMS, INC., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

See the full DCTH record — start free

14-day free trial, no credit card. For research purposes only; not investment advice.